In contrast, both the protein and mRNA expression levels of active caspase‐3 and Bax were significantly higher in the Alzheimer's disease than in the control group and sham groups, while Bcl‐2 expression levels were significantly lower (P < .01). This evidence concerns the gene BAX and Alzheimer disease.